Clinical Trial Update: A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss [NA]

View source ↗

Summary

Clinical trial update shows EH002 gene therapy aimed at otoferlin gene mutation–mediated congenital hearing loss is actively recruiting; no trial phase details …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hearing Loss
• Otoferlin-related Deafness
• Sensorineural Hearing Loss

Drugs mentioned

• EH002 gene therapy (EH002)

Snippet

Sponsor: Yilai Shu | Conditions: DFNB9, Congenital Hearing Loss | NA | Status: RECRUITING